Zepbound (tirzepatide) is a brand-name injectable prescription drug manufactured by Eli Lilly for chronic weight management in people with obesity or overweight
If youre wondering whether you might be a good candidate for Mounjaro or other GLP-1 receptor agonists, this article provides the essential information you need to make an informed decision with your healthcare provider
Gastrointestinal side effects: Semaglutide can cause gastrointestinal side effects such as vomiting, diarrhea, and nausea that cause direct fluid loss and electrolyte imbalance, which may lead to dehydration
Subcutaneous injection delivers the peptide directly into the bloodstream, bypassing digestive degradation making it the preferred route for musculoskeletal or systemic applications
Understanding which foods to limit helps you navigate your dietary choices more effectively and maintain comfort throughout your treatment journey
Secondary outcomes The secondary outcomes are as follows: type 2 diabetes, glucose, HbA1c, insulin, lipid profile (LDL-cholesterol, HDL-cholesterol, triglycerides and apolipoprotein B), systolic blood pressure, diastolic blood pressure, and body mass index (BMI), which are well-established risk factors for CVD in clinical practice, or recently identified to be related to CVD in MR, such as apolipoprotein B [30, 31]
